Your browser is no longer supported. Please, upgrade your browser.
BDTX Black Diamond Therapeutics, Inc. monthly Stock Chart
BDTX [NASD]
Black Diamond Therapeutics, Inc.
Index- P/E- EPS (ttm)-1.72 Insider Own2.10% Shs Outstand35.93M Perf Week3.22%
Market Cap1.21B Forward P/E- EPS next Y-2.49 Insider Trans-49.44% Shs Float34.29M Perf Month5.20%
Income-54.50M PEG- EPS next Q-0.63 Inst Own94.90% Short Float8.78% Perf Quarter17.51%
Sales- P/S- EPS this Y-294.80% Inst Trans-3.07% Short Ratio13.79 Perf Half Y-17.17%
Book/sh9.11 P/B3.73 EPS next Y-22.10% ROA-17.90% Target Price49.25 Perf Year-
Cash/sh9.34 P/C3.63 EPS next 5Y- ROE-22.30% 52W Range17.63 - 46.25 Perf YTD-13.98%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-26.57% Beta-
Dividend %- Quick Ratio29.70 Sales past 5Y- Gross Margin- 52W Low92.63% ATR2.03
Employees32 Current Ratio29.70 Sales Q/Q- Oper. Margin- RSI (14)58.95 Volatility5.92% 6.22%
OptionableNo Debt/Eq0.00 EPS Q/Q-75.60% Profit Margin- Rel Volume2.41 Prev Close33.54
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume218.18K Price33.96
Recom1.60 SMA203.89% SMA507.32% SMA2004.48% Volume512,085 Change1.25%
Nov-24-20Initiated Berenberg Buy $58
May-04-20Initiated H.C. Wainwright Buy $53
Feb-24-20Initiated JP Morgan Overweight $42
Feb-24-20Initiated Jefferies Buy
Feb-24-20Initiated Cowen Outperform
Feb-24-20Initiated Canaccord Genuity Buy $50
Nov-24-20 07:45AM  
Nov-20-20 07:45AM  
Nov-11-20 07:45AM  
Nov-10-20 07:45AM  
Oct-26-20 07:45AM  
Oct-12-20 07:45AM  
Oct-03-20 08:00AM  
Sep-29-20 07:45AM  
Sep-10-20 07:45AM  
Sep-08-20 04:05PM  
Aug-11-20 07:45AM  
Aug-10-20 08:42AM  
Aug-05-20 07:45AM  
Aug-04-20 07:45AM  
Jul-30-20 09:58AM  
Jul-28-20 07:45AM  
Jun-16-20 07:45AM  
May-27-20 07:45AM  
May-13-20 05:15PM  
May-12-20 07:45AM  
May-06-20 07:45AM  
May-05-20 11:46AM  
Feb-24-20 09:37AM  
Jan-30-20 04:29PM  
Black Diamond Therapeutics, Inc., a precision oncology medicine company, discovers and develops small molecule, tumor-agnostic therapies. Its lead product candidate is BDTX-189, an inhibitor of non-canonical and oncogenic mutations of ErbB kinases epidermal growth factor receptor (EGFR) and tyrosine-protein kinase. The company is also developing allosteric-EGFR mutation inhibitors; and various early stage pipeline programs targeting allosteric mutations in kinases related to cancer and/or rare genetic diseases. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was founded in 2014 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bolzon Bradley J PhDDirectorNov 19Sale33.01130,0174,291,861968,954Nov 23 04:39 PM
Versant Venture Capital VI, L.10% OwnerNov 19Sale33.01114,8543,791,3314,818,600Nov 23 04:41 PM
Versant Venture Capital VI, L.10% OwnerNov 19Sale33.0115,163500,531968,954Nov 23 04:41 PM
Bolzon Bradley J PhDDirectorNov 18Sale33.0953617,738984,117Nov 19 09:19 PM
Versant Venture Capital VI, L.10% OwnerNov 18Sale33.09632,085984,117Nov 19 09:19 PM
Versant Venture Capital VI, L.10% OwnerNov 18Sale33.0947315,6534,933,454Nov 19 09:19 PM
Versant Venture Capital VI, L.10% OwnerNov 17Sale33.0548916,161984,180Nov 19 09:19 PM
Versant Venture Capital VI, L.10% OwnerNov 17Sale33.053,705122,4504,933,927Nov 19 09:19 PM
Bolzon Bradley J PhDDirectorNov 17Sale33.054,194138,611984,180Nov 19 09:19 PM
Bolzon Bradley J PhDDirectorNov 16Sale33.012006,603984,669Nov 17 07:28 PM
Versant Venture Capital VI, L.10% OwnerNov 16Sale33.0123759984,669Nov 17 07:33 PM
Versant Venture Capital VI, L.10% OwnerNov 16Sale33.011775,8434,937,632Nov 17 07:33 PM
Versant Venture Capital VI, L.10% OwnerNov 13Sale33.7752517,731984,692Nov 17 07:33 PM
Versant Venture Capital VI, L.10% OwnerNov 13Sale33.773,975134,2534,937,809Nov 17 07:33 PM
Bolzon Bradley J PhDDirectorNov 13Sale33.774,500151,984984,692Nov 17 07:28 PM
Hatzis-Schoch BrentSee RemarksNov 12Option Exercise3.204,07813,0507,078Nov 13 04:25 PM
Versant Venture Capital VI, L.10% OwnerNov 12Sale34.151,81962,116985,217Nov 13 07:47 PM
Versant Venture Capital VI, L.10% OwnerNov 12Sale34.1513,779470,5264,941,784Nov 13 07:47 PM
Bolzon Bradley J PhDDirectorNov 12Sale34.1515,598532,642985,217Nov 13 07:46 PM
Hatzis-Schoch BrentSee RemarksNov 12Sale33.994,078138,6073,000Nov 13 04:25 PM
Roberts Christopher D.Chief Scientific OfficerNov 11Option Exercise10.865,00054,3005,000Nov 13 04:26 PM
Roberts Christopher D.Chief Scientific OfficerNov 11Sale34.905,000174,5000Nov 13 04:26 PM
Bolzon Bradley J PhDDirectorNov 11Sale34.7312,617438,217987,036Nov 12 05:38 PM
Versant Venture Capital VI, L.10% OwnerNov 11Sale34.731,47151,091987,036Nov 12 05:41 PM
Versant Venture Capital VI, L.10% OwnerNov 11Sale34.7311,146387,1275,646,377Nov 12 05:41 PM
Versant Venture Capital VI, L.10% OwnerNov 10Sale33.833,145106,381988,507Nov 12 05:41 PM
Versant Venture Capital VI, L.10% OwnerNov 10Sale33.8323,821805,7555,657,523Nov 12 05:41 PM
Bolzon Bradley J PhDDirectorNov 10Sale33.8326,966912,136988,507Nov 12 05:38 PM
Leggett ThomasChief Financial OfficerNov 09Option Exercise10.863,00032,5803,000Nov 12 05:00 PM
Leggett ThomasChief Financial OfficerNov 09Sale32.963,00098,8920Nov 12 05:00 PM
Versant Venture Capital VI, L.10% OwnerNov 09Sale33.0673524,296991,652Nov 10 07:24 PM
Bolzon Bradley J PhDDirectorNov 09Sale33.066,300208,250991,652Nov 10 07:24 PM
Versant Venture Capital VI, L.10% OwnerNov 09Sale33.065,565183,9545,681,344Nov 10 07:24 PM
Versant Venture Capital VI, L.10% OwnerNov 06Sale33.1336211,993992,387Nov 10 07:24 PM
Versant Venture Capital VI, L.10% OwnerNov 06Sale33.132,73890,7065,686,909Nov 10 07:24 PM
Bolzon Bradley J PhDDirectorNov 06Sale33.133,100102,698992,387Nov 10 07:24 PM
Versant Venture Capital VI, L.10% OwnerNov 05Sale33.151,03234,208992,749Nov 06 04:44 PM
Versant Venture Capital VI, L.10% OwnerNov 05Sale33.157,816259,0795,689,647Nov 06 04:44 PM
Bolzon Bradley J PhDDirectorNov 05Sale33.158,848293,287992,749Nov 06 04:49 PM
Bolzon Bradley J PhDDirectorNov 04Sale33.142,50082,839993,781Nov 06 04:49 PM
Versant Venture Capital VI, L.10% OwnerNov 04Sale33.142929,676993,781Nov 06 04:44 PM
Versant Venture Capital VI, L.10% OwnerNov 04Sale33.142,20873,1645,697,463Nov 06 04:44 PM
Roberts Christopher D.Chief Scientific OfficerNov 03Option Exercise10.862,50027,1502,500Nov 04 08:37 PM
Roberts Christopher D.Chief Scientific OfficerNov 03Sale31.952,50079,8730Nov 04 08:37 PM
Epstein David M.See RemarksNov 02Option Exercise6.423,00019,260723,923Nov 03 07:56 PM
Epstein David M.See RemarksNov 02Sale31.1412,000373,656711,923Nov 03 07:56 PM
Versant Venture Capital VI, L.10% OwnerOct 27Sale33.03933,072994,073Oct 28 05:58 PM
Versant Venture Capital VI, L.10% OwnerOct 27Sale33.0370723,3545,699,671Oct 28 05:58 PM
Bolzon Bradley J PhDDirectorOct 27Sale33.0380026,426994,073Oct 28 05:51 PM
Bolzon Bradley J PhDDirectorOct 26Sale33.308,103269,867994,166Oct 28 05:51 PM
Versant Venture Capital VI, L.10% OwnerOct 26Sale33.3094531,473994,166Oct 28 05:58 PM
Versant Venture Capital VI, L.10% OwnerOct 26Sale33.307,158238,3945,700,378Oct 28 05:58 PM
Bolzon Bradley J PhDDirectorOct 19Sale33.434,233141,513995,111Oct 20 08:03 PM
Versant Venture Capital VI, L.10% OwnerOct 19Sale33.4349416,515995,111Oct 20 08:09 PM
Versant Venture Capital VI, L.10% OwnerOct 19Sale33.433,739124,9985,707,536Oct 20 08:09 PM
Versant Venture Capital VI, L.10% OwnerOct 16Sale33.571,01634,110995,605Oct 20 08:09 PM
Versant Venture Capital VI, L.10% OwnerOct 16Sale33.577,697258,4105,711,275Oct 20 08:09 PM
Bolzon Bradley J PhDDirectorOct 16Sale33.578,713292,520995,605Oct 20 08:03 PM
Bolzon Bradley J PhDDirectorOct 15Sale33.032,80092,496996,621Oct 20 08:03 PM
Versant Venture Capital VI, L.10% OwnerOct 15Sale33.0332710,802996,621Oct 20 08:09 PM
Versant Venture Capital VI, L.10% OwnerOct 15Sale33.032,47381,6945,718,972Oct 20 08:09 PM
Versant Venture Capital VI, L.10% OwnerOct 14Sale33.0964221,244996,948Oct 15 07:22 PM
Versant Venture Capital VI, L.10% OwnerOct 14Sale33.094,859160,7875,721,445Oct 15 07:22 PM
Bolzon Bradley J PhDDirectorOct 14Sale33.095,501182,031996,948Oct 15 07:26 PM
Bolzon Bradley J PhDDirectorOct 13Sale33.3911,739391,984997,590Oct 15 07:26 PM
Versant Venture Capital VI, L.10% OwnerOct 13Sale33.391,36945,713997,590Oct 15 07:22 PM
Versant Venture Capital VI, L.10% OwnerOct 13Sale33.3910,370346,2715,726,304Oct 15 07:22 PM
Hatzis-Schoch BrentSee RemarksOct 12Option Exercise3.204,07813,0507,078Oct 14 04:32 PM
Versant Venture Capital VI, L.10% OwnerOct 12Sale33.11471,556998,959Oct 13 07:41 PM
Versant Venture Capital VI, L.10% OwnerOct 12Sale33.1135311,6875,736,674Oct 13 07:41 PM
Hatzis-Schoch BrentSee RemarksOct 12Sale32.704,078133,3313,000Oct 14 04:32 PM
Bolzon Bradley J PhDDirectorOct 12Sale33.1140013,243998,959Oct 13 07:48 PM
Bolzon Bradley J PhDDirectorOct 09Sale33.673,800127,933999,006Oct 13 07:48 PM
Versant Venture Capital VI, L.10% OwnerOct 09Sale33.6744314,914999,006Oct 13 07:41 PM
Versant Venture Capital VI, L.10% OwnerOct 09Sale33.673,357113,0185,737,027Oct 13 07:41 PM
Leggett ThomasChief Financial OfficerOct 08Option Exercise10.863,00032,5803,000Oct 09 04:12 PM
Versant Venture Capital VI, L.10% OwnerOct 08Sale33.472,14971,934999,449Oct 13 07:41 PM
Versant Venture Capital VI, L.10% OwnerOct 08Sale33.4716,276544,8145,740,384Oct 13 07:41 PM
Bolzon Bradley J PhDDirectorOct 08Sale33.4718,425616,748999,449Oct 13 07:48 PM
Leggett ThomasChief Financial OfficerOct 08Sale33.533,000100,5760Oct 09 04:12 PM
Bolzon Bradley J PhDDirectorOct 07Sale33.5627,836934,0791,041,206Oct 08 07:14 PM
Versant Venture Capital VI, L.10% OwnerOct 07Sale33.563,246108,9241,041,206Oct 08 07:14 PM
Versant Venture Capital VI, L.10% OwnerOct 07Sale33.5624,590825,1545,756,660Oct 08 07:14 PM
Versant Venture Capital VI, L.10% OwnerOct 06Sale33.262,11070,1761,044,452Oct 08 07:14 PM
Versant Venture Capital VI, L.10% OwnerOct 06Sale33.2615,980531,4775,781,250Oct 08 07:14 PM
Bolzon Bradley J PhDDirectorOct 06Sale33.2618,090601,6541,044,452Oct 08 07:14 PM
Roberts Christopher D.Chief Scientific OfficerOct 05Option Exercise10.862,50027,1502,500Oct 07 04:27 PM
Roberts Christopher D.Chief Scientific OfficerOct 05Sale31.282,50078,1880Oct 07 04:27 PM
Epstein David M.See RemarksOct 01Option Exercise6.423,00019,260732,923Oct 02 05:07 PM
Epstein David M.See RemarksOct 01Sale30.3312,000363,962720,923Oct 02 05:07 PM
INGRAM ROBERT ALEXANDERDirectorSep 30Buy30.465,000152,2855,000Oct 01 04:06 PM
Leggett ThomasChief Financial OfficerSep 14Option Exercise10.863,00032,5803,000Sep 16 06:09 PM
Hatzis-Schoch BrentSee RemarksSep 14Option Exercise3.204,07813,0507,078Sep 16 06:11 PM
Hatzis-Schoch BrentSee RemarksSep 14Sale31.044,078126,5833,000Sep 16 06:11 PM
Leggett ThomasChief Financial OfficerSep 14Sale31.003,00093,0000Sep 16 06:09 PM
Roberts Christopher D.Chief Scientific OfficerSep 03Option Exercise10.862,50027,1502,500Sep 04 05:27 PM
Roberts Christopher D.Chief Scientific OfficerSep 03Sale29.592,50073,9870Sep 04 05:27 PM
Versant Venture Capital VI, L.10% OwnerAug 11Sale33.0888329,2111,125,778Aug 12 07:57 PM
Versant Venture Capital VI, L.10% OwnerAug 11Sale33.086,692221,3806,797,230Aug 12 07:57 PM
Bolzon Bradley J PhDDirectorAug 11Sale33.087,575250,5911,125,778Aug 12 07:46 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.